Literature DB >> 10515869

The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit.

G Berrozpe1, I Timokhina, S Yukl, Y Tajima, M Ono, A D Zelenetz, P Besmer.   

Abstract

The Kit and PDGFRa receptor tyrosine kinases are encoded in close proximity at the murine white spotting (W) and patch (Ph) loci. Whereas W mutations affect hematopoiesis, melanogenesis, and gametogenesis, the Ph mutation affects melanogenesis and causes early lethality in homozygotes. The W(sh), W(57), and Ph mutations diminish Kit expression in certain cell types such as mast cells and enhance it in others. The W(sh), W(57), and Ph mutations arose from deletions and inversions affecting sequences in between the Kit and PDGFRa genes. We have determined the precise location of the breakpoint of the W(sh) inversion and the endpoints of the W(57) deletion upstream of the Kit transcription start site and examined the effect of these mutations on Kit expression in mast cells and hematopoietic stem cells and lineage progenitors. Our results indicate that positive elements controlling Kit expression in mast cells mapping in between -23 and -154 kb from the transcription start site can be dissociated from negative elements controlling Kit misexpression during embryonic development in the vicinity of the PDGFRa gene. In addition, we have identified two clusters of hypersensitive sites in mast cells at -23 -28 kb and -147 -154 kb from the Kit gene transcription start site. Analysis of these hypersensitive sites in mutant mast cells indicates a role for HS4-6 in Kit expression in mast cells. These findings provide a molecular basis for the phenotype of these Kit expression mutations and they provide insight into the complex mechanisms governing the regulation of Kit expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515869

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

Review 1.  Mast cells and metabolic syndrome.

Authors:  Jie Zhang; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice.

Authors:  P J Wolters; J Mallen-St Clair; C C Lewis; S A Villalta; P Baluk; D J Erle; G H Caughey
Journal:  Clin Exp Allergy       Date:  2005-01       Impact factor: 5.018

3.  Exchange of GATA factors mediates transitions in looped chromatin organization at a developmentally regulated gene locus.

Authors:  Huie Jing; Christopher R Vakoc; Lei Ying; Sean Mandat; Hongxin Wang; Xingwu Zheng; Gerd A Blobel
Journal:  Mol Cell       Date:  2008-02-01       Impact factor: 17.970

4.  Green fluorescent protein transgene driven by Kit regulatory sequences is expressed in hematopoietic stem cells.

Authors:  Francesco Cerisoli; Letizia Cassinelli; Giuseppe Lamorte; Stefania Citterio; Francesca Bertolotti; Maria Cristina Magli; Sergio Ottolenghi
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

5.  Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy.

Authors:  Peter A Nigrovic; Daniel H D Gray; Tatiana Jones; Jenny Hallgren; Frank C Kuo; Blair Chaletzky; Michael Gurish; Diane Mathis; Christophe Benoist; David M Lee
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

6.  Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment.

Authors:  George S Hui; Caryn N Hashimoto
Journal:  Int Immunopharmacol       Date:  2008-04-03       Impact factor: 4.932

7.  S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms.

Authors:  F Roviezzo; R Sorrentino; A Bertolino; L De Gruttola; M Terlizzi; A Pinto; M Napolitano; G Castello; B D'Agostino; A Ianaro; R Sorrentino; G Cirino
Journal:  Br J Pharmacol       Date:  2015-01-23       Impact factor: 8.739

8.  Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.

Authors:  Maciej Chichlowski; Greg S Westwood; Soman N Abraham; Laura P Hale
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

9.  Mast cells are an essential hematopoietic component for polyp development.

Authors:  Elias Gounaris; Susan E Erdman; Clifford Restaino; Michael F Gurish; Daniel S Friend; Fotini Gounari; David M Lee; Guoying Zhang; Jonathan N Glickman; Kichul Shin; Varada P Rao; Theofilos Poutahidis; Ralph Weissleder; Kelly M McNagny; Khashayarsha Khazaie
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

10.  Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection.

Authors:  Pierre Guermonprez; Julie Helft; Carla Claser; Stephanie Deroubaix; Henry Karanje; Anna Gazumyan; Guillaume Darasse-Jèze; Stephanie B Telerman; Gaëlle Breton; Heidi A Schreiber; Natalia Frias-Staheli; Eva Billerbeck; Marcus Dorner; Charles M Rice; Alexander Ploss; Florian Klein; Melissa Swiecki; Marco Colonna; Alice O Kamphorst; Matthew Meredith; Rachel Niec; Constantin Takacs; Fadi Mikhail; Aswin Hari; David Bosque; Tom Eisenreich; Miriam Merad; Yan Shi; Florent Ginhoux; Laurent Rénia; Britta C Urban; Michel C Nussenzweig
Journal:  Nat Med       Date:  2013-05-19       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.